Quanex Building Products Q2 sales rise 70% to $452.5 million; guidance reaffirmed
Quanex reported second-quarter results for the three months ended April 30, 2025, with net sales up 70% to $452.5 million, mostly from the Tyman acquisition, while diluted EPS fell to $0.44 from $0.46. The company reaffirmed its fiscal 2025 guidance and raised its cost synergy target to about $45 million, up from $30 million.
Key points
- Net sales were $452.5 million versus $266.2 million a year earlier; Tyman contributed $190.1 million.
- Diluted EPS was $0.44 versus $0.46; adjusted diluted EPS was $0.60 versus $0.73.
- Fiscal 2025 guidance reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million.
- Cost synergy target raised to about $45 million; the company repurchased about $23.5 million of stock in the quarter.
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.